Reaching 7 Thousand Cases In 2025, Active Monitoring Of Dengue Vaccinations Is Carried Out In DKI Jakarta

Dengue is an infection caused by the virus (DENV), which is transmitted to humans through the bite of infected female Aedes aegypti and Aedes albopictus mosquitoes.

These infections can vary from asymptomatic, mild fever, to serious conditions such as dengue fever that can lead to death.

This dengue infection is still a significant burden for the world community, including Indonesia. The Indonesian Ministry of Health noted that until September 22, 2025, there were 115,138 cases of dengue nationally with 479 deaths, with 57 percent of cases occurring on the island of Java.

As in DKI Jakarta until September 22, 2025, the number of dengue cases was recorded at 7,247 cases with 12 deaths. In this case, DKI Jakarta as a province with high population mobility requires a layered strategy so that protection for the community can be further strengthened.

Various control measures have been taken by the DKI Jakarta Provincial Government, ranging from mosquito vector control programs such as 3M Plus and G1R1, sustainable public education, to technology-based interventions.

However, to overcome dengue infection more optimally, the DKI Jakarta government is working with the Faculty of Medicine, University of Indonesia (FKUI) to vaccinate dengue. The vaccination is carried out by actively monitoring for three years for vaccine recipients.

"But we realize that dengue control requires an integrated strategy. To provide more optimal protection for the community, another approach is needed that is also innovative," said Drg. Ani Ruspitawati, MM, Head of the DKI Jakarta Provincial Health Office represented by dr. Ovi Norfiana, MKM, Head of Disease Prevention and Control, at the Inauguration of the Dengue Vaccination Active Monitoring event at the South Jakarta Mayor's Office, on Monday, September 29, 2025.

"Therefore, we together with FKUI carry out dengue vaccinations, along with active monitoring in South Jakarta as a complementary step. We believe that this cross-sector collaboration will further strengthen protection efforts, as well as pave the way for the people of Jakarta to benefit from various forms of health innovation," he added.

In this dengue vaccination active monitoring program, the group included in the monitoring is 30 thousand children. In DKI Jakarta itself, especially in South Jakarta, consists of 15 thousand children, with 10 thousand who get vaccinated.

With the active monitoring of dengue vaccination, it is hoped that it can reduce the burden of dengue infection in Indonesia in the future. This program is also called a reflection to present relevant and sustainable health solutions related to infectious diseases such as dengue in the community.

"Through this active monitoring of dengue vaccination in elementary school children in South Jakarta, FKUI together with the DKI Jakarta Provincial Health Office with the support of Takeda (the private sector involved) seeks to provide a more systematic mechanism for monitoring vaccine effectiveness," said Professor of the Department of Children's Health Sciences, Faculty of Medicine, University of Indonesia, Prof. Dr. dr Sri Rezeki Hadinegoro, SpA(K).

This collaboration is not only a tangible manifestation of the role of academics in strengthening public health resilience, but also reflects our enthusiasm to present relevant and sustainable health solutions amid the challenges of infectious diseases such as dengue, continued the Dean of the Faculty of Medicine, University of Indonesia, Prof. Dr.dr H. Ari Fahrial Syam, SpPD-KGEH, MMB, FINASIM, FACP.

Meanwhile, the Indonesian Ministry of Health expressed full support for the dengue vaccination active monitoring program in Jakarta. This activity is said to be a good collaboration to deal with dengue infections, which is in accordance with the strategy of the Ministry of Health and the World Health Organization (WHO).

"Today's activities are an example of a collaboration that we really appreciate, as well as in line with WHO's global strategy for Nuclear Tropical Diseases 2020-2030 with the target of Zero dengue death in 2030. With the synergy of various parties, we are optimistic that this target can be achieved and we can suppress the burden of dengue in the country," concluded Plh. Director of Infectious Diseases, Ministry of Health of the Republic of Indonesia, dr. Fadjar Surya Mensing Silalahi.